Literature DB >> 33910241

Ambulatory Care Sensitive Conditions Among All-Payer Claimants With Intellectual and Developmental Disabilities.

Kimberly G Phillips1, Jeanne S Wishengrad1, Andrew J Houtenville1.   

Abstract

Inpatient hospitalizations for ambulatory care sensitive conditions (ACSC) among beneficiaries with and without intellectual and developmental disabilities (IDD) were examined using Medicaid and commercial claims from 2010-2014 in New Hampshire. IDD was defined with International Classification of Diseases, Ninth Edition, Clinical Modification (ICD-9-CM) codes using algorithms from the Centers for Medicare and Medicaid Services, and inpatient encounters were identified using the Healthcare Effectiveness Data and Information Set. In adjusted analyses, beneficiaries with IDD had more hospitalizations for ACSC than those without IDD in both insurance groups. Differences in patterns of ACSC prevalence, comorbidities, and hospital admissions between the commercially and Medicaid-insured groups show the value of using all-payer claims data, when possible, to understand health needs and health care utilization of insurance beneficiaries with IDD. ©AAIDD.

Entities:  

Keywords:  ambulatory care sensitive conditions; health care utilization; inpatient care; intellectual and developmental disabilities

Year:  2021        PMID: 33910241     DOI: 10.1352/1944-7558-126.3.203

Source DB:  PubMed          Journal:  Am J Intellect Dev Disabil        ISSN: 1944-7558


  2 in total

1.  The Characteristics and Outcomes of Patients Transported by Ambulance Due to Ambulatory Care Sensitive Condition: A Population-Based Descriptive Study in Osaka, Japan.

Authors:  Yusuke Katayama; Atsushi Kanehara; Yuya Yamashita; Tetsuhisa Kitamura; Jun Oda
Journal:  Front Public Health       Date:  2022-06-30

Review 2.  Using Ambulatory Care Sensitive Conditions to Assess Primary Health Care Performance during Disasters: A Systematic Review.

Authors:  Alessandro Lamberti-Castronuovo; Martina Valente; Chiara Aleni; Ives Hubloue; Luca Ragazzoni; Francesco Barone-Adesi
Journal:  Int J Environ Res Public Health       Date:  2022-07-27       Impact factor: 4.614

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.